Exchange Traded Concepts »

Inhibrx Biosciences shares owned by Exchange Traded Concepts

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Exchange Traded Concepts from 13F filings

Historical chart of Exchange Traded Concepts investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Exchange Traded Concepts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Exchange Traded Concepts

Quarter filed Position value Share count Share price at filing
2025-03-31 $128k 9.1k 13.99
2024-12-31 $148k 9.6k 15.40

More positions owned by Exchange Traded Concepts

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Series Trust State Street Spd (SPLG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Listed Fds Tr Roundhill Magnif (MAGS)
Tesla Motors (TSLA)
Apple (AAPL)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Spdr Series Trust State Street Spd (SPAB)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Exchange Traded Concepts

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Woodline Partners
Millennium Management
Partner Fund Management
Caligan Partners
Geode Capital Management
State Street Corporation
Readystate Asset Management
Kennedy Capital Management

View all funds holding Inhibrx Biosciences